Skip to main content
. 2022 Jul 6;5:669. doi: 10.1038/s42003-022-03630-3

Fig. 4. Nanobodies for immune assays testing nasal swab specimens.

Fig. 4

a P158 nanobody-based western blotting of nasal swab specimens. Patients with fever (+) and confirmed to be positive for SARS-CoV-2 by PCR test (+); healthy volunteers with no fever (–) and negative by PCR test (–) were compared (NT: not tested). b P158 nanobody-based western blotting assays of swabs from emergency fever patients. A to D and I to P were confirmed positive for SARS-CoV-2 by PCR test; E to H were not confirmed to be positive by the PCR test. c P158 nanobody-lined lateral flow assays of swabs from emergency fever patients. Control and patient samples are the same as those in a and b, respectively. d P158 nanobody-captured ELISA. Means of detection signals of the nasal swab specimens are shown. Data are representative of one independent experiment out of two biologically independent experiments.